Cite
APA Citation
Moiseenko, F., Stepanova, M., Zhabina, A., Myslik, A., Klimenko, V., Rysev, N., Artemieva, E., Shelekhova, K., Bogdanov, A., Volkov, N., & Moiseenko, V. (n.d.). 42PPrediction of PFS using a dynamic assessment of ctDNA in patients with EGFR mutated NSCLC with osimertinib therapy. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100094879659.0x000054